No clear answer
Omega-3 fatty acids: slow disability worsening in relapsing and progressive MS
relapsing and progressive MS · Vitamin D and nutritional supplements
Trials have tried this, but none was a controlled phase 2 or 3 trial with a readable result.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Omega-3 fatty acids, phase 2 | Phase1|phase2 | 54 | 2014 | Missed its main goal | Not counted: tested as the comparator |
Counted: 0. Will count later: 0. Not counted: 1.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as No clear answer
Related hypotheses
Assembled by software from public sources.